Hidenori Mizugaki

Hidenori Mizugaki

UNVERIFIED PROFILE

Are you Hidenori Mizugaki?   Register this Author

Register author
Hidenori Mizugaki

Hidenori Mizugaki

Publications by authors named "Hidenori Mizugaki"

Are you Hidenori Mizugaki?   Register this Author

22Publications

575Reads

23Profile Views

Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.

Int J Clin Oncol 2017 Apr 5;22(2):257-268. Epub 2016 Nov 5.

First Department of Medicine, Hokkaido University School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-016-1060-3DOI Listing
April 2017

Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer.

Int J Clin Oncol 2017 Feb 23;22(1):59-69. Epub 2016 Aug 23.

First Department of Medicine, Hokkaido University School of Medicine, North 15, West 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10147-016-1031-8
Publisher Site
http://dx.doi.org/10.1007/s10147-016-1031-8DOI Listing
February 2017

A phase I study of resminostat in Japanese patients with advanced solid tumors.

Cancer Chemother Pharmacol 2015 Jun 7;75(6):1155-61. Epub 2015 Apr 7.

Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2741-8DOI Listing
June 2015

Current Status of Single-Agent Phase I Trials in Japan: Toward Globalization.

J Clin Oncol 2015 Jun 27;33(18):2051-61. Epub 2015 Apr 27.

All authors: National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.4953DOI Listing
June 2015

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors.

Cancer Chemother Pharmacol 2014 Jul 22;74(1):15-23. Epub 2014 Apr 22.

Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-014-2467-z
Publisher Site
http://dx.doi.org/10.1007/s00280-014-2467-zDOI Listing
July 2014

CD133 expression: a potential prognostic marker for non-small cell lung cancers.

Int J Clin Oncol 2014 Apr 12;19(2):254-9. Epub 2013 Mar 12.

First Department of Medicine, Hokkaido University School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10147-013-0541-x
Publisher Site
http://dx.doi.org/10.1007/s10147-013-0541-xDOI Listing
April 2014

Secondary osteosarcoma developing 10 years after chemoradiotherapy for non-small-cell lung cancer.

Jpn J Clin Oncol 2014 Feb 13;44(2):191-4. Epub 2013 Dec 13.

*Division of Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 1040045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt192DOI Listing
February 2014

Expression of Bim, Noxa, and Puma in non-small cell lung cancer.

BMC Cancer 2012 Jul 12;12:286. Epub 2012 Jul 12.

First Department of Medicine, Hokkaido University School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438016PMC
July 2012